What is the chemical mediator involved in a scald burn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chemical Mediator in a Spilled Hot Water Burn

Prostaglandins (D) are the primary chemical mediator in a spilled hot water burn, playing a crucial role in the inflammatory response that follows thermal injury.

Pathophysiology of Burn Injury

When hot water contacts the skin, it causes tissue damage that initiates an inflammatory cascade:

  • Burn injuries trigger inflammation, hypermetabolism, and capillary leakage, leading to the release of various inflammatory mediators 1
  • At the site of injury, several inflammatory mediators are released, including monoamines, cytokines, prostanoids (prostaglandins), and peptides 1
  • These mediators are sensed by nociceptors and activate C and Aδ fibers, which transmit pain signals to the dorsal horn of the spinal cord 1

Role of Prostaglandins in Burn Injury

Prostaglandins are the predominant chemical mediator in thermal burns for several reasons:

  • Prostaglandins are synthesized by the enzyme cyclooxygenase (COX) and play a major role in the inflammatory response following tissue damage 2
  • They function as vasodilators that potentiate plasma exudation produced by other permeability-increasing mediators like histamine or bradykinin 3
  • Prostaglandins are responsible for many of the cardinal signs of inflammation seen in burns, including pain, swelling, and edema 2
  • The inducible enzyme COX-2 is particularly important in producing pro-inflammatory prostaglandins after tissue injury 2

Other Chemical Mediators in Burns

While prostaglandins are the primary mediator, other substances also contribute to the burn response:

  • Bradykinins (option B) do play a role in burn inflammation, but they primarily act by sensitizing nociceptors to heat stimuli through a mechanism that depends on prostaglandin synthesis via both COX-1 and COX-2 4
  • Serotonin (5-HT) (option A) functions more as a transmitter in the inhibitory pain system rather than as a primary inflammatory mediator in burns 1
  • Thromboxane (option C) is another prostanoid but is not the predominant mediator in thermal burns 1

Clinical Implications

Understanding prostaglandins as the key mediator in burns has important treatment implications:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) can help manage burn pain by inhibiting COX enzymes, thus reducing prostaglandin production 2
  • Multimodal analgesia is recommended for burn pain management, with titration based on validated pain assessment scales 1
  • Cooling the burn site can help reduce pain and limit burn depth progression by affecting the inflammatory cascade 1
  • Covering burns with appropriate dressings can reduce pain by protecting nerve endings from external stimulation 1

Management Considerations

When treating thermal burns, consider these evidence-based approaches:

  • For small to moderate burns (< 20% TBSA in adults, < 10% in children), cooling the burn can limit deepening and reduce pain 1
  • Short-acting opioids and ketamine are effective for managing burn-induced pain 1
  • Non-pharmacological treatments such as cooling limited burned surfaces and covering burns with appropriate dressings can improve pain control 1
  • In severe cases, general anesthesia may be required for wound care procedures 1

Understanding that prostaglandins are the primary chemical mediator in thermal burns helps guide appropriate anti-inflammatory and analgesic therapy to improve patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical aspects of COX-2 inhibitors.

Drugs of today (Barcelona, Spain : 1998), 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.